According to this latest study, the 2020 growth of Soliris (Eculizumab) will have significant change from previous year. By the most conservative estimates of global Soliris (Eculizumab) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Soliris (Eculizumab) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Soliris (Eculizumab) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Plasma Exchange
Plasma Infusion
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
PNH
aHUS
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Alexion
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Soliris (Eculizumab) Market Size 2016-2026
2.1.2 Soliris (Eculizumab) Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Soliris (Eculizumab) Segment by Type
2.2.1 Plasma Exchange
2.2.2 Plasma Exchange
2.3 Soliris (Eculizumab) Market Size by Type
2.3.1 Global Soliris (Eculizumab) Market Size CAGR by Type
2.3.2 Global Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
2.4 Soliris (Eculizumab) Segment by Application
2.4.1 PNH
2.4.2 aHUS
2.4.3 Other
2.5 Soliris (Eculizumab) Market Size by Application
2.5.1 Global Soliris (Eculizumab) Market Size CAGR by Application
2.5.2 Global Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
3 Global Soliris (Eculizumab) by Players
3.1 Soliris (Eculizumab) Market Size Market Share by Players
3.1.1 Global Soliris (Eculizumab) Revenue by Players (2019-2021E)
3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Players (2019-2021E)
3.2 Global Soliris (Eculizumab) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Soliris (Eculizumab) by Regions
4.1 Soliris (Eculizumab) Market Size by Regions (2016-2021)
4.2 Americas Soliris (Eculizumab) Market Size Growth (2016-2021)
4.3 APAC Soliris (Eculizumab) Market Size Growth (2016-2021)
4.4 Europe Soliris (Eculizumab) Market Size Growth (2016-2021)
4.5 Middle East & Africa Soliris (Eculizumab) Market Size Growth (2016-2021)
5 Americas
5.1 Americas Soliris (Eculizumab) Market Size by Country (2016-2021)
5.2 Americas Soliris (Eculizumab) Market Size by Type (2016-2021)
5.3 Americas Soliris (Eculizumab) Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Soliris (Eculizumab) Market Size by Region (2016-2021)
6.2 APAC Soliris (Eculizumab) Market Size by Type (2016-2021)
6.3 APAC Soliris (Eculizumab) Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Soliris (Eculizumab) by Country (2016-2021)
7.2 Europe Soliris (Eculizumab) Market Size by Type (2016-2021)
7.3 Europe Soliris (Eculizumab) Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Soliris (Eculizumab) by Region (2016-2021)
8.2 Middle East & Africa Soliris (Eculizumab) Market Size by Type (2016-2021)
8.3 Middle East & Africa Soliris (Eculizumab) Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Soliris (Eculizumab) Market Forecast
10.1 Global Soliris (Eculizumab) Forecast by Regions (2021-2026)
10.1.1 Global Soliris (Eculizumab) Forecast by Regions (2021-2026)
10.1.2 Americas Soliris (Eculizumab) Forecast
10.1.3 APAC Soliris (Eculizumab) Forecast
10.1.4 Europe Soliris (Eculizumab) Forecast
10.1.5 Middle East & Africa Soliris (Eculizumab) Forecast
10.2 Americas Soliris (Eculizumab) Forecast by Countries (2021-2026)
10.2.1 United States Soliris (Eculizumab) Market Forecast
10.2.2 Canada Soliris (Eculizumab) Market Forecast
10.2.3 Mexico Soliris (Eculizumab) Market Forecast
10.2.4 Brazil Soliris (Eculizumab) Market Forecast
10.3 APAC Soliris (Eculizumab) Forecast by Region (2021-2026)
10.3.1 China Soliris (Eculizumab) Market Forecast
10.3.2 Japan Soliris (Eculizumab) Market Forecast
10.3.3 Korea Soliris (Eculizumab) Market Forecast
10.3.4 Southeast Asia Soliris (Eculizumab) Market Forecast
10.3.5 India Soliris (Eculizumab) Market Forecast
10.3.6 Australia Soliris (Eculizumab) Market Forecast
10.4 Europe Soliris (Eculizumab) Forecast by Country (2021-2026)
10.4.1 Germany Soliris (Eculizumab) Market Forecast
10.4.2 France Soliris (Eculizumab) Market Forecast
10.4.3 UK Soliris (Eculizumab) Market Forecast
10.4.4 Italy Soliris (Eculizumab) Market Forecast
10.4.5 Russia Soliris (Eculizumab) Market Forecast
10.5 Middle East & Africa Soliris (Eculizumab) Forecast by Region (2021-2026)
10.5.1 Egypt Soliris (Eculizumab) Market Forecast
10.5.2 South Africa Soliris (Eculizumab) Market Forecast
10.5.3 Israel Soliris (Eculizumab) Market Forecast
10.5.4 Turkey Soliris (Eculizumab) Market Forecast
10.5.5 GCC Countries Soliris (Eculizumab) Market Forecast
10.6 Global Soliris (Eculizumab) Forecast by Type (2021-2026)
10.8 Global Soliris (Eculizumab) Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Alexion
11.1.1 Alexion Company Information
11.1.2 Alexion Soliris (Eculizumab) Product Offered
11.1.3 Alexion Soliris (Eculizumab) Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Alexion Main Business Overview
11.1.5 Alexion Latest Developments
...
12 Research Findings and Conclusion
List of Tables
Table 1. Soliris (Eculizumab) Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Plasma Exchange
Table 3. Major Players of Plasma Infusion
Table 4. Soliris (Eculizumab) Market Size CAGR by Type (2016-2021) & ($ Millions)
Table 5. Global Soliris (Eculizumab) Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Table 7. Soliris (Eculizumab) Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Soliris (Eculizumab) Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
Table 10. Global Soliris (Eculizumab) Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Soliris (Eculizumab) Revenue Market Share by Players (2019-2021E)
Table 12. Global Soliris (Eculizumab) Key Players Head office and Products Offered
Table 13. Soliris (Eculizumab) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Soliris (Eculizumab) Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Soliris (Eculizumab) Market Size Market Share by Regions 2016-2021
Table 18. Americas Soliris (Eculizumab) Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Soliris (Eculizumab) Market Size Market Share by Country (2016-2021)
Table 20. Americas Soliris (Eculizumab) Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Table 22. Americas Soliris (Eculizumab) Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
Table 24. APAC Soliris (Eculizumab) Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Soliris (Eculizumab) Market Size Market Share by Region (2016-2021)
Table 26. APAC Soliris (Eculizumab) Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Table 28. APAC Soliris (Eculizumab) Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
Table 30. Europe Soliris (Eculizumab) Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Soliris (Eculizumab) Market Size Market Share by Country (2016-2021)
Table 32. Europe Soliris (Eculizumab) Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Table 34. Europe Soliris (Eculizumab) Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Soliris (Eculizumab) Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Soliris (Eculizumab) Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Soliris (Eculizumab) Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Soliris (Eculizumab)
Table 43. Key Application and Potential Industries of Soliris (Eculizumab)
Table 44. Key Challenges of Soliris (Eculizumab)
Table 45. Key Trends of Soliris (Eculizumab)
Table 46. Global Soliris (Eculizumab) Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Soliris (Eculizumab) Market Size Market Share Forecast by Regions
Table 48. Global Soliris (Eculizumab) Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Soliris (Eculizumab) Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Soliris (Eculizumab) Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Soliris (Eculizumab) Market Size Market Share Forecast by Application (2021-2026)
Table 52. Alexion Details, Company Type, Soliris (Eculizumab) Area Served and Its Competitors
Table 53. Alexion Soliris (Eculizumab) Product Offered
Table 54. Alexion Soliris (Eculizumab) Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Alexion Main Business
Table 56. Alexion Latest Developments
List of Figures
Figure 1. Soliris (Eculizumab) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Soliris (Eculizumab) Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Soliris (Eculizumab) Market Size Market Share by Type (2016-2021)
Figure 7. Soliris (Eculizumab) in PNH
Figure 8. Global Soliris (Eculizumab) Market: PNH (2016-2021) & ($ Millions)
Figure 9. Soliris (Eculizumab) in aHUS
Figure 10. Global Soliris (Eculizumab) Market: aHUS (2016-2021) & ($ Millions)
Figure 11. Soliris (Eculizumab) in Other
Figure 12. Global Soliris (Eculizumab) Market: Other (2016-2021) & ($ Millions)
Figure 13. Global Soliris (Eculizumab) Market Size Market Share by Application in 2020
Figure 14. Global Soliris (Eculizumab) Revenue Market Share by Player in 2020
Figure 15. Global Soliris (Eculizumab) Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Soliris (Eculizumab) Market Size 2016-2021 ($ Millions)
Figure 17. APAC Soliris (Eculizumab) Market Size 2016-2021 ($ Millions)
Figure 18. Europe Soliris (Eculizumab) Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Soliris (Eculizumab) Market Size 2016-2021 ($ Millions)
Figure 20. Americas Soliris (Eculizumab) Market Size Market Share by Country in 2020
Figure 21. Americas Soliris (Eculizumab) Market Size Market Share by Type in 2020
Figure 22. Americas Soliris (Eculizumab) Market Size Market Share by Application in 2020
Figure 23. United States Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Soliris (Eculizumab) Market Size Market Share by Regions in 2020
Figure 27. APAC Soliris (Eculizumab) Market Size Market Share by Type in 2020
Figure 28. APAC Soliris (Eculizumab) Market Size Market Share by Application in 2020
Figure 29. China Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Soliris (Eculizumab) Market Size Market Share by Countries in 2020
Figure 36. Europe Soliris (Eculizumab) Market Size Market Share by Type in 2020
Figure 37. Europe Soliris (Eculizumab) Market Size Market Share by Application in 2020
Figure 38. Germany Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Application in 2020
Figure 46. Egypt Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Countries Soliris (Eculizumab) Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 52. APAC Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 53. Europe Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 55. United States Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 56. Canada Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 59. China Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 60. Japan Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 61. Korea Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 63. India Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 64. Australia Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 65. Germany Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 66. France Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 67. UK Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 68. Italy Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 69. Russia Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 70. Spain Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 73. Israel Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)
Figure 75. GCC Countries Soliris (Eculizumab) Market Size 2021-2026 ($ Millions)